PharmaCorp Rx Inc. (TSXV:PCRX)
Canada · Delayed Price · Currency is CAD 0.5100
0.00 (0.00%)
At close: Jun 1, 2026
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 88.78 million as of June 1, 2026. Its market cap has increased by 57.15% in one year.
Market Cap
88.78M
Enterprise Value
67.79M
Revenue
20.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.51
Market Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 88.78M, an increase of 3,599.24%. That is a compound annual growth rate of 167.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 88.78M | 16.89% |
| Dec 31, 2025 | 75.95M | 19.91% |
| Dec 31, 2024 | 63.34M | 427.83% |
| Dec 30, 2022 | 12.00M | 400.00% |
| Sep 29, 2022 | 2.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 4.00B |
| Extendicare | 3.08B |
| Trulieve Cannabis | 2.52B |
| Green Thumb Industries | 2.47B |
| Charlotte's Web Holdings | 110.82M |
| Zentek | 96.67M |
| NetraMark Holdings | 82.55M |
| Cannabix Technologies | 78.62M |